Status: Recruiting
Clinical Impact Through AI-assisted MS Care - A Retrospective Multi-center Observational Study.
The RECLAIM study aims to gather a centralized and harmonized dataset, enabling the secondary use of data for building AI-based models that will support diagnosis and prognosis of individual Multiple Sclerosis patient's disease course and treatment response in a real-world setting. Additionally, the data will be used to generate further insights on Multiple Sclerosis progression as well as to develop the tools to monitor this progression.
Participants needed: 7,000
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: icometrixUpdated: Dec 12, 2025Locations: 3
Eligibility criteria
Patients must have a confirmed diagnosis of MS, NMOSD, MOGAD, CIS or RIS. [+1]
Patients under 18 years of age will be excluded. [+1]